Latest filing published 31 Jan 2020 for Alaunos Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -46.0%Entry US$645.00 · Close at T+365 US$348.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David M. Mauney MD: trading record in brief
David M. Mauney MD appears in our data through filings on Alaunos Therapeutics, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 8 November 2017 and the latest from 29 January 2020.
Market trades split into 1 purchase (€17k) and 1 sale (€91k). Taken together, the sales exceed the purchases by €74k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. In 2020 alone, the filings show no purchases and 1 sale.
The latest filing, published on 31 January 2020, reports a share grant in Alaunos Therapeutics, Inc. The most recent open-market purchase was published on 9 November 2017, 3,287 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David M. Mauney MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 80,500 shares0Common StockSEC:0001209191-20-005787:0
- 22,394 shares@ US$4.55100.0% of flowCommon StockSEC:0001209191-20-001180:0
- 159,010 shares0Common StockSEC:0001209191-19-002774:0
- 4,270 shares@ US$4.6815.9% of flowCommon StockSEC:0001209191-17-059986:0Canonical exit: 6 Feb 2018 (T+90)
4 of 4 declarations